Goldman Sachs Upgrades Mead Johnson To Buy

Analysts at Goldman Sachs upgraded Mead Johnson Nutrition Company

from Neutral to Buy. The target price for Mead Johnson Nutrition has been raised from $91 to $107. Mead Johnson shares have jumped 26.13% over the past 52 weeks, while the S&P 500 index has gained 17.95% in the same period. Mead Johnson's shares gained 0.30% to close at $92.87 yesterday.